The Scientist

» Nobel Prize, evolution and disease/medicine

Most Recent

image: Skin-to-Liver Cell Shortcut

Skin-to-Liver Cell Shortcut

By | February 23, 2014

Researchers use an adapted reprogramming technique to generate hepatocytes for the repopulation of an injured mouse liver.

1 Comment

image: How a Microbe Resists Its Own Antibiotics

How a Microbe Resists Its Own Antibiotics

By | February 20, 2014

Researchers reveal the molecular mechanisms of Streptomyces platensis’s defense from its own antibiotics, which inhibit fatty acid synthesis in other microbes.

0 Comments

image: OCD-Linked Canine Genes

OCD-Linked Canine Genes

By | February 19, 2014

Dogs can suffer from obsessive compulsive disorder just like some humans do, and now researchers have identified a genetic basis for their spastic behavior.

3 Comments

image: Bodybuilders Take Breast Cancer Drug

Bodybuilders Take Breast Cancer Drug

By | February 17, 2014

Tamoxifen, an endocrine therapy for women with breast cancer, is found in a supplement marketed to bodybuilders.

0 Comments

image: Week in Review: February 10–14

Week in Review: February 10–14

By | February 14, 2014

First Ancient North American genome; cannabinoids connect hunger with olfaction and eating; biotechs explore crowdfunding; confronting creationism

0 Comments

image: Pesticide Linked to Alzheimer’s

Pesticide Linked to Alzheimer’s

By | February 10, 2014

Researchers find that DDT may increase the risk of the neurodegenerative disease.

0 Comments

image: Triglyceride Clock

Triglyceride Clock

By | February 10, 2014

The timing of meals affects the levels of lipids in the livers of mice, according to a study.

0 Comments

image: Neural Target for Autism?

Neural Target for Autism?

By | February 7, 2014

Mouse and rat models of the developmental disorder responded positively to a drug given to their mothers a day before birth.

0 Comments

image: Opinion: Confronting Creationism

Opinion: Confronting Creationism

By | February 7, 2014

Five reasons why scientists should stay out of debates over evolution.

55 Comments

image: $230M for Big Disease

$230M for Big Disease

By | February 5, 2014

The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham